Your browser doesn't support javascript.
loading
Relapsed or refractory large B-cell lymphoma after chimeric antigen receptor T-cell therapy: Current challenges and therapeutic options.
Del Toro-Mijares, Raul; Oluwole, Olalekan; Jayani, Reena V; Kassim, Adetola A; Savani, Bipin N; Dholaria, Bhagirathbhai.
  • Del Toro-Mijares R; Escuela de Medicina, Tecnologico de Monterrey, Monterrey, Mexico.
  • Oluwole O; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Jayani RV; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kassim AA; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Savani BN; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Dholaria B; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Br J Haematol ; 201(1): 15-24, 2023 04.
Article en En | MEDLINE | ID: mdl-36709623
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Receptores Quiméricos de Antígenos Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Receptores Quiméricos de Antígenos Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article